Rituximab News and Research

RSS
Rituximab is approved by the Food and Drug Administration (FDA) to be used alone or with other drugs to treat certain types of B-cell non-Hodgkin lymphoma. It is also approved to be used with methotrexate to treat rheumatoid arthritis. Rituximab is also being studied in the treatment of other types of cancer and other conditions.
Knocking out Mcl1 protein could aid leukemia treatment

Knocking out Mcl1 protein could aid leukemia treatment

Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells

Anadys Pharmaceuticals presents data showing ANA773 promotes anti-tumor activity of killer cells

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

GlaxoSmithKline initiates study of PROMACTA in chronic idiopathic thrombocytopenic purpura

Rituximab shown to significantly inhibit structural damage of joints caused by rheumatoid arthritis

Rituximab shown to significantly inhibit structural damage of joints caused by rheumatoid arthritis

The efficacy and safety of Rituximab in patients with active rheumatoid arthritis

The efficacy and safety of Rituximab in patients with active rheumatoid arthritis

Natural killer cells and antibody-based immune function

Natural killer cells and antibody-based immune function

Novel therapy for chronic graft-versus-host disease

Novel therapy for chronic graft-versus-host disease

Novel therapy for chronic graft-versus-host disease (GVHD) using Rituximab

Novel therapy for chronic graft-versus-host disease (GVHD) using Rituximab

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

Study to Rituximab's potential to preserve insulin production in newly diagnosed type 1 diabetics

FDA approves Rituxan (Rituximab)

FDA approves Rituxan (Rituximab)

Rituximab maintenance therapy dramatically improves survival for patients with lymphoma

Rituximab maintenance therapy dramatically improves survival for patients with lymphoma

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

Targeted cancer therapies: Another step forward

New treatment advances for patients with follicular lymphoma

New treatment advances for patients with follicular lymphoma

New monoclonal antibody that targets immune system B cells shows promise for treating leukemias

New monoclonal antibody that targets immune system B cells shows promise for treating leukemias

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

Experimental vaccine can prime the immune system to help fight an aggressive form of lymphoma

MabThera highly effective in treating rheumatoid arthritis

MabThera highly effective in treating rheumatoid arthritis

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Rituximab, used to treat rheumatoid arthritis (RA) is safe and effective

Rituximab provides new hope for people with lupus

Rituximab provides new hope for people with lupus

Radioimmunotherapy streamlines non-Hodgkin's lymphoma treatment

Radioimmunotherapy streamlines non-Hodgkin's lymphoma treatment